Pediatric ovarian malignancies

how efficacious are current staging practices?

Sarah C. Oltmann, Nilda M. Garcia, Robert Barber, Barry Hicks, Anne C. Fischer

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Purpose: Conventional staging is not routinely practiced because of a lack of preoperative indicators for pediatric ovarian malignancy. Children's Oncology Group (COG) developed guidelines for germ cell tumors to revise staging to correlate with primary pediatric ovarian pathology. Are COG guidelines being used, and are they applicable to all pediatric ovarian malignancies? Methods: A 151/2-year retrospective review of operative ovarian masses from a single academic center was performed. Results: There were 424 patients identified, with 46 malignancies (11%). Most were stage I (73%). Complete COG staging was performed in 24%. Each staging component performed was as follows: oophorectomy (91%), examination with or without biopsy of omentum (72%), peritoneum (67%), retroperitoneum (63%), contralateral ovary (56%), and washings (46%). Advanced stages had visible findings at exploration to guide biopsies. Of site-directed biopsies, 40.5% were positive, whereas all random biopsies (n = 38) were negative. Two recurrences and all mortalities (n = 4) had complete initial COG operative staging. Mean duration of follow-up was 3.62 ± 0.365 years. Conclusion: The COG staging is not consistently followed. All cases of advanced disease were visibly obvious and confirmed with site-directed biopsies. Random samplings were all negative and did not impact stage. Negative outcomes reflected inherent tumor biology not deviation from COG staging. The COG guidelines appear to be sufficient for all pediatric ovarian malignancies.

Original languageEnglish (US)
Pages (from-to)1096-1102
Number of pages7
JournalJournal of Pediatric Surgery
Volume45
Issue number6
DOIs
StatePublished - 2010

Fingerprint

Pediatrics
Biopsy
Neoplasms
Guidelines
Omentum
Germ Cell and Embryonal Neoplasms
Peritoneum
Ovariectomy
Ovary
Pathology
Recurrence
Mortality

Keywords

  • Operative staging
  • Ovarian malignancy
  • Ovarian mass
  • Pediatric surgery

ASJC Scopus subject areas

  • Surgery
  • Pediatrics, Perinatology, and Child Health
  • Medicine(all)

Cite this

Pediatric ovarian malignancies : how efficacious are current staging practices? / Oltmann, Sarah C.; Garcia, Nilda M.; Barber, Robert; Hicks, Barry; Fischer, Anne C.

In: Journal of Pediatric Surgery, Vol. 45, No. 6, 2010, p. 1096-1102.

Research output: Contribution to journalArticle

Oltmann, Sarah C. ; Garcia, Nilda M. ; Barber, Robert ; Hicks, Barry ; Fischer, Anne C. / Pediatric ovarian malignancies : how efficacious are current staging practices?. In: Journal of Pediatric Surgery. 2010 ; Vol. 45, No. 6. pp. 1096-1102.
@article{f4fa580496e544f4bb07ec8882ec4caa,
title = "Pediatric ovarian malignancies: how efficacious are current staging practices?",
abstract = "Purpose: Conventional staging is not routinely practiced because of a lack of preoperative indicators for pediatric ovarian malignancy. Children's Oncology Group (COG) developed guidelines for germ cell tumors to revise staging to correlate with primary pediatric ovarian pathology. Are COG guidelines being used, and are they applicable to all pediatric ovarian malignancies? Methods: A 151/2-year retrospective review of operative ovarian masses from a single academic center was performed. Results: There were 424 patients identified, with 46 malignancies (11{\%}). Most were stage I (73{\%}). Complete COG staging was performed in 24{\%}. Each staging component performed was as follows: oophorectomy (91{\%}), examination with or without biopsy of omentum (72{\%}), peritoneum (67{\%}), retroperitoneum (63{\%}), contralateral ovary (56{\%}), and washings (46{\%}). Advanced stages had visible findings at exploration to guide biopsies. Of site-directed biopsies, 40.5{\%} were positive, whereas all random biopsies (n = 38) were negative. Two recurrences and all mortalities (n = 4) had complete initial COG operative staging. Mean duration of follow-up was 3.62 ± 0.365 years. Conclusion: The COG staging is not consistently followed. All cases of advanced disease were visibly obvious and confirmed with site-directed biopsies. Random samplings were all negative and did not impact stage. Negative outcomes reflected inherent tumor biology not deviation from COG staging. The COG guidelines appear to be sufficient for all pediatric ovarian malignancies.",
keywords = "Operative staging, Ovarian malignancy, Ovarian mass, Pediatric surgery",
author = "Oltmann, {Sarah C.} and Garcia, {Nilda M.} and Robert Barber and Barry Hicks and Fischer, {Anne C.}",
year = "2010",
doi = "10.1016/j.jpedsurg.2010.02.069",
language = "English (US)",
volume = "45",
pages = "1096--1102",
journal = "Journal of Pediatric Surgery",
issn = "0022-3468",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Pediatric ovarian malignancies

T2 - how efficacious are current staging practices?

AU - Oltmann, Sarah C.

AU - Garcia, Nilda M.

AU - Barber, Robert

AU - Hicks, Barry

AU - Fischer, Anne C.

PY - 2010

Y1 - 2010

N2 - Purpose: Conventional staging is not routinely practiced because of a lack of preoperative indicators for pediatric ovarian malignancy. Children's Oncology Group (COG) developed guidelines for germ cell tumors to revise staging to correlate with primary pediatric ovarian pathology. Are COG guidelines being used, and are they applicable to all pediatric ovarian malignancies? Methods: A 151/2-year retrospective review of operative ovarian masses from a single academic center was performed. Results: There were 424 patients identified, with 46 malignancies (11%). Most were stage I (73%). Complete COG staging was performed in 24%. Each staging component performed was as follows: oophorectomy (91%), examination with or without biopsy of omentum (72%), peritoneum (67%), retroperitoneum (63%), contralateral ovary (56%), and washings (46%). Advanced stages had visible findings at exploration to guide biopsies. Of site-directed biopsies, 40.5% were positive, whereas all random biopsies (n = 38) were negative. Two recurrences and all mortalities (n = 4) had complete initial COG operative staging. Mean duration of follow-up was 3.62 ± 0.365 years. Conclusion: The COG staging is not consistently followed. All cases of advanced disease were visibly obvious and confirmed with site-directed biopsies. Random samplings were all negative and did not impact stage. Negative outcomes reflected inherent tumor biology not deviation from COG staging. The COG guidelines appear to be sufficient for all pediatric ovarian malignancies.

AB - Purpose: Conventional staging is not routinely practiced because of a lack of preoperative indicators for pediatric ovarian malignancy. Children's Oncology Group (COG) developed guidelines for germ cell tumors to revise staging to correlate with primary pediatric ovarian pathology. Are COG guidelines being used, and are they applicable to all pediatric ovarian malignancies? Methods: A 151/2-year retrospective review of operative ovarian masses from a single academic center was performed. Results: There were 424 patients identified, with 46 malignancies (11%). Most were stage I (73%). Complete COG staging was performed in 24%. Each staging component performed was as follows: oophorectomy (91%), examination with or without biopsy of omentum (72%), peritoneum (67%), retroperitoneum (63%), contralateral ovary (56%), and washings (46%). Advanced stages had visible findings at exploration to guide biopsies. Of site-directed biopsies, 40.5% were positive, whereas all random biopsies (n = 38) were negative. Two recurrences and all mortalities (n = 4) had complete initial COG operative staging. Mean duration of follow-up was 3.62 ± 0.365 years. Conclusion: The COG staging is not consistently followed. All cases of advanced disease were visibly obvious and confirmed with site-directed biopsies. Random samplings were all negative and did not impact stage. Negative outcomes reflected inherent tumor biology not deviation from COG staging. The COG guidelines appear to be sufficient for all pediatric ovarian malignancies.

KW - Operative staging

KW - Ovarian malignancy

KW - Ovarian mass

KW - Pediatric surgery

UR - http://www.scopus.com/inward/record.url?scp=77953819064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953819064&partnerID=8YFLogxK

U2 - 10.1016/j.jpedsurg.2010.02.069

DO - 10.1016/j.jpedsurg.2010.02.069

M3 - Article

VL - 45

SP - 1096

EP - 1102

JO - Journal of Pediatric Surgery

JF - Journal of Pediatric Surgery

SN - 0022-3468

IS - 6

ER -